PUBLISHER: The Business Research Company | PRODUCT CODE: 1946657
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946657
Ophthalmic lasers are specialized medical devices that utilize concentrated light beams to perform precise surgical procedures on the eye, addressing conditions such as cataracts, glaucoma, and retinal disorders. These lasers offer a minimally invasive and highly targeted approach to vision correction and the management of eye diseases.
The primary types of ophthalmic lasers include femtosecond lasers, excimer lasers, neodymium-doped yttrium aluminum garnet (Nd,YAG) lasers, diode lasers, and other variations. Femtosecond lasers, for instance, emit extremely short pulses of light, with each pulse lasting just a few femtoseconds (1 femtosecond = 10-15 seconds). In ophthalmology, femtosecond lasers are used for precise corneal surgeries, such as LASIK flap creation and cataract lens fragmentation. These lasers find applications in various medical procedures, including refractive error treatment, cataract treatment, glaucoma treatment, diabetic retinopathy treatment, age-related macular degeneration (AMD) treatment, among others. End-users of ophthalmic lasers encompass hospitals, ambulatory service centers, and ophthalmic clinics.
Tariffs are influencing the ophthalmic lasers market by increasing import costs for optical components, precision electronics, and laser subsystems, thereby elevating manufacturing and procurement expenses for femtosecond, excimer, nd:yag, and diode laser platforms. These effects are most pronounced across hospital and ophthalmic clinic end-users in Asia-Pacific and North American regions that depend on cross-border component sourcing, with refractive error treatment and cataract treatment segments experiencing higher capital equipment price volatility. At the same time, tariffs are encouraging selective localization of production and assembly, which is fostering regional supplier development and supporting limited positive outcomes in terms of supply-chain diversification and domestic capability building.
The ophthalmic lasers market research report is one of a series of new reports from The Business Research Company that provides ophthalmic lasers market statistics, including ophthalmic lasers industry global market size, regional shares, competitors with a ophthalmic lasers market share, detailed ophthalmic lasers market segments, market trends and opportunities, and any further data you may need to thrive in the ophthalmic lasers industry. This ophthalmic lasers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The ophthalmic lasers market size has grown strongly in recent years. It will grow from $1.42 billion in 2025 to $1.49 billion in 2026 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to growing incidence of cataracts and refractive errors, early adoption of lasik and prk laser procedures, expansion of hospital-based ophthalmic surgery infrastructure, rising healthcare expenditure in developed markets, regulatory approvals for ophthalmic laser treatment systems.
The ophthalmic lasers market size is expected to see strong growth in the next few years. It will grow to $1.83 billion in 2030 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to aging population in emerging economies, increasing surgical volumes in ambulatory service centers, rising burden of diabetes and dr-related complications, technology upgrades in femtosecond and nd:yag laser platforms, expanding demand for elective vision correction procedures. Major trends in the forecast period include rising demand for minimally invasive ophthalmic laser surgeries, increasing adoption of outpatient and ambulatory laser procedures, growing prevalence of diabetic retinopathy and age-related macular degeneration, expanding use of laser-assisted cataract and refractive error treatments, rising integration of multi-application and versatile ophthalmic laser platforms.
The increasing healthcare expenditure is anticipated to drive the growth of the ophthalmic lasers market in the coming years. Healthcare expenditure refers to the financial resources allocated for healthcare services, including medical goods, public health activities, and administration. This growth is influenced by factors such as an aging population, advancements in medical technology, rising pharmaceutical costs, and the growing prevalence of chronic conditions. Higher healthcare expenditure supports the ophthalmic lasers market by enabling increased investments in advanced laser technologies and improving access to precise eye care treatments for a broader patient base. For instance, in June 2024, Health Affairs, a U.S.-based academic journal, reported that national healthcare expenditure in the U.S. is expected to rise from $4,799.3 billion in 2023 to $5,048.8 billion in 2024, a $249.5 billion increase. Therefore, the rise in healthcare spending is fueling the growth of the ophthalmic laser market.
Major companies operating in the ophthalmic lasers market are emphasizing technological innovation, including fully automated Direct Selective Laser Trabeculoplasty (DSLT) systems, to support efficient first-line treatment of glaucoma and ocular hypertension while enhancing patient comfort and optimizing clinical workflows. Fully automated DSLT systems combine precise laser delivery, integrated eye-tracking technology, and user-friendly interfaces to remove the need for manual gonio lens placement, lower dependence on specialized training, and enable ophthalmologists to safely and effectively treat a higher number of patients. For example, in February 2025, Alcon, a Switzerland-based eye care and medical device company, introduced the Voyager DSLT in the United States. The system administers 120 fully automated laser pulses per treatment using SureTrac eye-tracking technology, ensuring accurate targeting of the trabecular meshwork, improving procedural efficiency, and expanding access to first-line glaucoma therapy while simplifying clinical operations for eye care professionals.
In April 2023, Necsel Intellectual Property Inc., a US-based company specializing in high-powered visible lasers, acquired Blue Sky Research Inc. for an undisclosed amount. This acquisition is aimed at expanding Blue Sky Research's product line, leveraging its global footprint and sales support, and enhancing its knowledge and intellectual property portfolio in the component and laser solutions markets. Blue Sky Research Inc. is a US-based manufacturer of high-performance fiber-coupled laser devices and modules for medical and ophthalmology applications.
Major companies operating in the ophthalmic lasers market are Abbott Laboratories, Alcon Laboratories Inc., Bausch & Lomb Incorporated, Coherent Inc., Carl Zeiss Meditec AG, Topcon Corporation, Lumenis Ltd., Johnson & Johnson Surgical Vision Inc., LUMIBIRD, Lutronic Corporation, Quantel Medical SAS, NIDEK CO. LTD, IRIDEX Corporation, Ellex Inc., Technolas Perfect Vision GmbH, LENSAR LLC, Lightmed GmbH, Ziemer Ophthalmic Systems AG, SCHWIND eye-tech-solutions GmbH & Co. KG, NoIR Laser Company LLC, DEKA Laser, A.R.C. Laser GmbH, ATL Lasertechnik GmbH, Norlase, Alna-Medicalsystem GmbH, Luxium Solutions LLC
North America was the largest region in the ophthalmic lasers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ophthalmic lasers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the ophthalmic lasers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The ophthalmic laser market consists of sales of solid-state lasers, lasers with fiber technology, and optically pumped semiconductor lasers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Ophthalmic Lasers Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses ophthalmic lasers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for ophthalmic lasers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ophthalmic lasers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.